Michael Elliott

Michael Elliott serves as the Board Director at Medicines Development for Global Health since October 2021, following a distinguished career in medical affairs and development at Gilead Sciences, where the role of Vice President for Europe, Middle East, Canada, and Australasia has been held since April 2012. Prior experience includes significant leadership positions at GlaxoSmithKline Pharmaceuticals, including Medical Director and Vice President for Asia Pacific, focusing on drug development and strategy. Michael's expertise in medical governance and ethics complements a strong educational background, including an MBA from Melbourne Business School and qualifications in medicine from the University of London and Charing Cross Hospital Medical School.